This compound is primarily used in the synthesis of modified nucleosides, which are essential in the development of antiviral and anticancer drugs. Its tert-butyldimethylsilyl (TBDMS) protecting group ensures selective reactivity during chemical modifications, making it valuable in oligonucleotide synthesis. Additionally, the incorporation of the fluorine atom enhances its potential as a biologically active molecule, particularly in targeting viral enzymes or cancer cells. It is also utilized in research to study the mechanisms of nucleoside analogs in therapeutic applications.